supp.fit

L-Carnitine: study protocols

184 study groups say how much L-Carnitine participants took a day. These are the doses the studies gave. They are not a recommendation.

L-Carnitine: what the research found →

Dose per serving from products

851 products in our catalogue print how much L-Carnitine a serving holds.

Most common: 250 mg to 500 mg, 20% of 851 products.

Dose per servingProducts
5 mg or less
7
5 mg to 10 mg
58
10 mg to 25 mg
66
25 mg to 50 mg
42
50 mg to 100 mg
75
100 mg to 250 mg
101
250 mg to 500 mg
169
500 mg to 1 g
159
1 g to 2.5 g
78
2.5 g to 5 g
95
over 5 g
1

Dose per serving from research

168 study groups in 131 studies say how much L-Carnitine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 45% of 168 study groups.

Daily doseStudy groups
250 mg or less
3
250 mg to 500 mg
10
500 mg to 1 g
32
1 g to 2.5 g
76
2.5 g to 5 g
39
over 5 g
8

Commonly used together

44 of 184 study groups took L-Carnitine with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Acetyl-L-Carnitine
13
Vitamin C
4
Vitamin E
4
Zinc
3

184 study groups

Study
Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial
2014 · Group A · Women with clomiphene-resistant PCOS
3 g—85
Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration
2000 · L-carnitine group · Adults with moderate to severe heart failure (NYHA class III to IV) caused by dilated cardiomyopathy
2 g1026 days37
Prevention by L-carnitine of interleukin-2 related cardiac toxicity during cancer immunotherapy
1993 · IL-2 plus L-carnitine · Advanced cancer patients with clinically important cardiac diseases
1 g6 weeks15
Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
2017 · L-carnitine group · Patients older than 14 years undergoing their first deceased-donor kidney transplantation
3 g4 days—
[L-carnitine improves sperm acrosin activity in male infertility patients]
2018 · LC group · Male infertility patients with low sperm acrosin activity; age not reported
3 g90 days180
A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication
2013 · PLC group · Chinese patients with intermittent claudication
2 g120 days120
The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study
1991 · L-carnitine group · Adults aged 40–65 with exercise-induced stable angina
2 g26 weeks100
Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study
2022 · L-carnitine group · Adults aged 19–65 with liver cirrhosis and covert hepatic encephalopathy
2 g24 weeks70
Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome
2024 · group 2 (L-carnitine) · Males aged 28–40 with chronic prostatitis/chronic pelvic pain syndrome and subfertility
2 g90 days50
Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome
2024 · group 4 (tadalafil/L-carnitine) · Males aged 28–40 with chronic prostatitis/chronic pelvic pain syndrome and subfertility
2 g90 days50
Adding L-carnitine to antagonist ovarian stimulation doesn't improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial
2024 · L-carnitine group · Women aged 20–37 with PCOS-related infertility undergoing IVF/ICSI
3 g8 weeks47
Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
2022 · group B · Patients with overt hepatic encephalopathy receiving rifaximin
1.5 g12 weeks41
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment
2011 · PLC 1 g/day group · Adults aged 18–75 with mild-to-moderate ulcerative colitis receiving stable oral aminosalicylate or thiopurine therapy
1 g—40
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment
2011 · PLC 2 g/day group · Adults aged 18–75 with mild-to-moderate ulcerative colitis receiving stable oral aminosalicylate or thiopurine therapy
2 g—39
Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy
1995 · L-propionylcarnitine · Patients with at least 2 anginal attacks per week and objective signs of ischemia with angina during bicycle exercise testing
1.5 g6 weeks37
The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial
2021 · L-carnitine group (LCG) · Women aged 45 years or older with obesity (BMI 25–35 kg/m²) and diagnosed knee osteoarthritis
1 g12 weeks34
L-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis
2015 · L-carnitine group · Overweight or obese women with mild to moderate knee osteoarthritis
750 mg8 weeks33
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial
2007 · levocarnitine group · centenarians with fatigue onset after even slight physical activity; sex not reported
2 g—32
The effects of L-carnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy
2000 · Group I · Adults with ischemic cardiomyopathy; mean age 64.3 years; 27 men and 4 women
2 g30 days31
Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure
1992 · propionyl-L-carnitine · Men and women aged 48–73 years with mild to moderate (NYHA class II and III) congestive heart failure, receiving chronic digitalis and diuretics treatment
1.5 g180 days30
L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study
2007 · L-carnitine group · Adults with celiac disease
2 g180 days30
Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults
2008 · L-Carnitine trial · Healthy men and women, mean age 30 ± 8 years
2 g3 weeks30
L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial
2016 · L-carnitine · Adults with hypothyroidism on levothyroxine treatment who continued to experience fatigue; mean age 50.0 years, 3 males and 57 females across the trial
1.98 g12 weeks30
L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms
2010 · L-carnitine group · Adults with NYHA class II symptoms, ejection fraction >45%, and documented grade 1 diastolic dysfunction
1.5 g90 days29
L-carnitine moderately improves the exercise tolerance in chronic stable angina
2000 · L-carnitine · Patients aged 56 ± 8 years with chronic stable angina; 30 men and 17 women across the study
2 g90 days28
Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial
2013 · L-carnitine treatment period · Adults aged 20 years or older with narcolepsy with cataplexy
510 mg8 weeks28
Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial
2016 · L-carnitine group · Community-dwelling Malaysian adults aged 60 years and older with prefrailty; men and women
1.5 g10 weeks26
[The clinical and hemodynamic effects of propionyl-L-carnitine in the treatment of congestive heart failure]
1992 · propionyl-L-carnitine group · Men and women aged 48–69 with mild-moderate congestive heart failure
2 g26 weeks25
Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial
2023 · L-carnitine + placebo · Women aged 19–49 with obesity (BMI 30–35 kg/m²), without the listed comorbidities
1 g8 weeks22
Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency
1999 · L-carnitine group · Patients with NYHA class II or III cardiac insufficiency
3 g120 days20
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes
2004 · Group 1 · Men with type 1 or type 2 diabetes and medically documented erectile dysfunction, unresponsive to sildenafil monotherapy; age not reported
2 g24 weeks20
[L-carnitine treatment patients with chronic cerebral ischemia]
2013 · First group · Adults aged 42–74 with dementia-stage chronic cerebral ischemia
1 g60 days20
[L-carnitine treatment patients with chronic cerebral ischemia]
2013 · Second group · Adults aged 42–74 with dementia-stage chronic cerebral ischemia
2 g60 days20
Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease
2025 · oral L-carnitine treatment group · Adults aged 20 or older undergoing peritoneal dialysis
2.25 g26 weeks13
The effects of acute L-carnitine supplementation on endurance performance of athletes
2014 · LK-3 · Candidate professional male footballers; age and health condition not stated
3 g1 day12
Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy
2015 · L-carnitine · Patients older than 14 years with biopsy-proven mitochondrial myopathy, chronic progressive external ophthalmoplegia, and exercise intolerance, mild fixed limb weakness, or myalgias
3 g8 weeks12
Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial
2019 · IGT carnitine · Adults aged 61–62 years, men and women, with impaired glucose tolerance
2 g36 days11
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial
2001 · Group A2 · Women receiving a fixed TSH-suppressive dose of L-T4, with iatrogenic hyperthyroidism
2 g60 days10
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial
2001 · Group B2 · Women receiving a fixed TSH-suppressive dose of L-T4, with iatrogenic hyperthyroidism
2 g120 days10
Influence of L-carnitine administration on maximal physical exercise
1990 · L-carnitine · Moderately trained young men; exact age and condition not reported
2 g1 day10
Effects of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance exercise
2008 · LCLT trial · Healthy, previously resistance-trained men; mean age 25.2 years
2 g23 days9
Effects of L- and DL-carnitine on patients with impaired exercise tolerance
1995 · L-carnitine treatment group · Adults with cardiac disease and impaired exercise tolerance; age range and sex not reported
900 mg2 weeks9
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial
1999 · propionyl-L-carnitine group · Patients with class II Fontaine peripheral arterial obliterative disease of the lower limbs
3 g90 days—
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication
2001 · propionyl-L-carnitine group · Patients with disabling claudication
2 g26 weeks—
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia
2005 · L-carnitine · Men aged 20–40 years with idiopathic asthenozoospermia
3 g26 weeks—
L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs
2006 · L-carnitine group (CG) · Adults with moderate-to-severe chronic obstructive pulmonary disease; mean age 66 ± 7 years
2 g6 weeks—
L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial
2010 · L-carnitine plus diet · Patients with nonalcoholic steatohepatitis (NASH); age and sex not stated
2 g24 weeks—
Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients
2010 · sibutramine plus L-carnitine · Patients with uncontrolled type 2 diabetes mellitus (HbA1c >8.0%); age and sex not stated
2 g1 year—
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients
2011 · orlistat plus L-carnitine · Adults with obese type 2 diabetes mellitus and HbA1c >8.0%
2 g1 year—
L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial
2012 · cilostazol/l-carnitine · Patients with peripheral artery disease and stable intermittent claudication
2 g180 days—
The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis
2012 · L-carnitine · patients with migraine
500 mg12 weeks—
Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
2015 · L-carnitine group, BCAA− patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; BCAA− subgroup
600 mg14 weeks—
L-Carnitine to Reduce Chemoradiotherapy-Induced Toxicity in Head and Neck Cancer: A Randomized Study
2025 · study arm · Patients with head and neck squamous cell carcinoma undergoing concurrent chemoradiation
1.5 g——
Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial
2021 · standard (control) arm · Children aged 15 years or younger with propionic acidemia or methylmalonic acidemia
150 mg/kg2 years17
Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia
2004 · group 3 · Adults with idiopathic or varicocele-associated oligoasthenospermia
2 g26 weeks106
Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia
2004 · group 2 · Adults with idiopathic or varicocele-associated oligoasthenospermia
2 g26 weeks101
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]
2005 · treatment group · men with oligoasthenozoospermia
2 g90 days90
Controlled study on L-carnitine therapeutic efficacy in post-infarction
1992 · L-carnitine group · Adults aged 39–86 years, both sexes, with recent myocardial infarction
4 g1 year81
Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome
2024 · group 6 (L-carnitine/Serenoa repens extract) · Males aged 28–40 with chronic prostatitis/chronic pelvic pain syndrome and subfertility
2 g90 days50
Multi-pharmacological treatment for young subfertile males with chronic prostatitis/chronic pelvic pain syndrome
2024 · group 7 (tadalafil/L-carnitine/Serenoa repens extract) · Males aged 28–40 with chronic prostatitis/chronic pelvic pain syndrome and subfertility
2 g90 days50
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue
2003 · levocarnitine group · elderly men and women with rapid muscle fatigue following slight physical activity
4 g30 days42
The effects of acute L-carnitine supplementation on endurance performance of athletes
2014 · LK-4 · Candidate professional male footballers; age and health condition not stated
4 g1 day14
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial
2001 · Group A4 · Women receiving a fixed TSH-suppressive dose of L-T4, with iatrogenic hyperthyroidism
4 g60 days10
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial
2001 · Group B4 · Women receiving a fixed TSH-suppressive dose of L-T4, with iatrogenic hyperthyroidism
4 g120 days10
A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia
2004 · combined l-carnitine and l-acetyl-carnitine treatment · Infertile men aged 20–40 years with oligo-astheno-teratozoospermia and abnormal baseline sperm parameters
2 g26 weeks—
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia
2005 · Combined L-carnitine and L-acetyl-carnitine · Men aged 20–40 years with idiopathic asthenozoospermia
2 g26 weeks—
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia
2010 · arm 3 · Patients with cancer-related anorexia/cachexia syndrome; age and sex not reported
4 g120 days—
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia
2010 · 3—L-carnitine 4 g/d · Patients with cancer-related anorexia/cachexia syndrome (CACS); age and sex not specified
4 g120 days—
[The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]
1993 · Group 1 · Patients with ischemic heart disease and multifocal ventricular extrasystolic arrhythmia; mean age 64 years, 20 men and 10 women across the study
6 g2 weeks—
[The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]
1993 · Group 3, combination treatment in the second week · Patients with ischemic heart disease and multifocal ventricular extrasystolic arrhythmia; mean age 64 years, 20 men and 10 women across the study
6 g7 days—
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]
1995 · Group A · Patients with effort angina and ventricular ectopic beats; age and sex not reported
6 g2 weeks—
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]
1995 · Group E · Patients with effort angina and ventricular ectopic beats; age and sex not reported
6 g2 weeks—
Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease
2016 · LC group · Adults with coronary artery disease; all participants were male, with mean age 71.9 years; diabetes, liver disease and renal disease were excluded.
1 g12 weeks20
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD
2006 · PLC group · Patients with type 2 diabetes (NIDDM) associated with peripheral arterial disease
2 g1 year—
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index
2024 · supplementation formulation (Proxeed Plus) · Men aged 18–50 years with infertility and oligo-, astheno- and/or teratozoospermia, with or without varicocele
1 g26 weeks—
Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life
2025 · Intervention Group · Adults with newly diagnosed overt Graves’ disease; mean age 48.51 years; 46 women and 14 men in the study overall
500 mg2 years30
Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial
2021 · carglumic acid arm · Children aged 15 years or younger with propionic acidemia or methylmalonic acidemia
150 mg/kg2 years21
[L-carnitine combined with coenzyme Q10 for idiopathic oligoasthenozoospermia: A double-blind randomized controlled trial]
2018 · LC group · Men with idiopathic oligoasthenozoospermia
20 mL90 days62
Effect of L-carnitine on the physical fitness of thalassemic patients
2007 · L-carnitine therapy · Patients with thalassemia major; ages and sex not reported
50 mg/kg26 weeks30
Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial
2021 · L-carnitine group · Children with type 1 diabetes mellitus for more than 3 years; ages and sex not specified
50 mg/kg120 days25
Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative study
2010 · group 1 · Men with idiopathic infertility
25 mg90 days20
Impact of L-carnitine supplementation on gastric emptying and bowel function in pediatric ketogenic diet therapy: a clinical trial
2024 · Arm I (L-carnitine supplementation group) · Children aged 12 months to 18 years with drug-resistant epilepsy starting ketogenic diet therapy
50 mg/kg90 days15
The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis
2012 · Mg-L-carnitine · patients with migraine
500 mg12 weeks—
l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial
2024 · L-carnitine · Children with confirmed autism spectrum disorder
150 mg10 weeks—
Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19
2021 · CMA group, phase 3 · Adults aged 18–66 with PCR-confirmed mild-to-moderate COVID-19 who did not require hospitalization
7.46 g2 weeks229
Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19
2021 · CMA group, phase 2 · Adults aged 19–66 with PCR-confirmed mild-to-moderate COVID-19 who did not require hospitalization
7.46 g2 weeks71
[L-carnitine combined with coenzyme Q10 for idiopathic oligoasthenozoospermia: A double-blind randomized controlled trial]
2018 · Combination group · Men with idiopathic oligoasthenozoospermia
20 mL90 days63
The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial
2025 · Alpha-linolenic plus L-carnitine group · Women aged 20–50 years with migraine
500 mg12 weeks40
Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial
2023 · L-carnitine + synbiotic · Women aged 19–49 with obesity (BMI 30–35 kg/m²), without the listed comorbidities
1 g8 weeks23
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia
2010 · arm 5 · Patients with cancer-related anorexia/cachexia syndrome; age and sex not reported
4 g120 days—
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia
2010 · 5—combination of the above · Patients with cancer-related anorexia/cachexia syndrome (CACS); age and sex not specified
4 g120 days—
The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial
2019 · Coenzyme Q10 and L-carnitine group · Men and women aged 20–40 years with migraine headache
500 mg8 weeks—
Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial
2021 · L-carnitine group · Children aged 6–18 years receiving hemodialysis
50 mg/kg10 weeks12
Effects of l-carnitine supplementation on cardiovascular and bone turnover markers in patients with pemphigus vulgaris under corticosteroids treatment: A randomized, double-blind, controlled trial
2019 · L-carnitine group · Patients with pemphigus vulgaris receiving corticosteroid treatment; age and sex not specified
2 g8 weeks24
Carbohydrate ingestion augments L-carnitine retention in humans
2007 · Study B, carbohydrate (CHO) trial · Adult men; age and health condition not specified
3 g2 weeks14
Carbohydrate ingestion augments L-carnitine retention in humans
2007 · Study B, flavored-water control (Con) trial · Adult men; age and health condition not specified
3 g2 weeks14
Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration
2009 · L-carnitine supplement · Healthy pregnant women, from the 13th week of gestation to term
500 mg—13
Metabolic changes induced by maximal exercise in human subjects following L-carnitine administration
1990 · L-carnitine · Ten moderately trained male subjects; age and health condition not specified
2 g1 day10
Carbohydrate ingestion augments L-carnitine retention in humans
2007 · Study A, carbohydrate (CHO) visit · Adult men; age and health condition not specified
3 g1 day8
Carbohydrate ingestion augments L-carnitine retention in humans
2007 · Study A, flavored-water control (Con) visit · Adult men; age and health condition not specified
3 g1 day8
Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia
2010 · carnitine group · Men and women with hyper-Lp(a) hyperlipoproteinemia receiving hemodialysis
1 g12 weeks—
[Using L- and acetyl-L-carnintines in combination with clomiphene citrate and antioxidant complex for treating idiopathic male infertility: a prospective randomized trial]
2017 · study group · Men aged 25–45 with idiopathic oligo-, astheno- and/or teratozoospermia
2 g120 days88
Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects
2013 · dietary supplement group · Healthy overweight men and women aged 25–45 years with BMI greater than 25 and less than 35 kg/m²
300 mg8 weeks50
A Pilot, Phase II, Observational, Case-Control, 1-Month Study on Asthenopia in Video Terminal Operators without Dry Eye: Contrast Sensitivity and Quality of Life before and after the Oral Consumption of a Fixed Combination of Zinc, L-Carnitine, Extract of Elderberry, Currant and Extract of Eleutherococcus
2021 · group T = treatment · VDT workers of any age and gender, without dry eye and with symptoms of ocular discomfort
50 mg30 days15
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
2012 · Arm 1: L-carnitine + celecoxib · Patients with cancer-related anorexia/cachexia syndrome; age and sex not stated
4 g120 days—
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
2012 · Arm 2: L-carnitine + celecoxib + megestrol acetate · Patients with cancer-related anorexia/cachexia syndrome; age and sex not stated
4 g120 days—
Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
2015 · L-carnitine group, BCAA+ patients · Japanese adults with intermediate-stage hepatocellular carcinoma and liver cirrhosis undergoing TACE; already receiving BCAA granules
600 mg14 weeks—
Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis
2013 · L-carnitine · Hemodialysis patients with total carnitine levels below 50 μmol/L
900 mg26 weeks51
A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction
1996 · carnitine group · Patients with suspected acute myocardial infarction; age and sex not reported
2 g4 weeks51
The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
2003 · L-carnitine group · Adults with newly diagnosed type 2 diabetes managed with dietary restriction and hypercholesterolemia; mean age 52 years
2 g26 weeks46
[Use of L-carnitine before percutaneous epididymal sperm aspiration-intracytoplasmic sperm injection for obstructive azoospermia]
2010 · L-carnitine group · Men with obstructive azoospermia; age not reported
2 g90 days43
L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes
2009 · L-carnitine group · Adults with type 2 diabetes
2 g90 days41
Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin
2009 · L-carnitine and simvastatin group · Adults with type 2 diabetes treated with simvastatin
2 g90 days40
Effects of l-Carnitine Supplementation on Serum Inflammatory Factors and Matrix Metalloproteinase Enzymes in Females with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2016 · L-carnitine group · Females with mild to moderate knee osteoarthritis
750 mg8 weeks36
Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study
2022 · intervention group · Adults aged 18–60 hospitalized with mild-to-moderate COVID-19
3 g5 days33
The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial
2024 · L-carnitine group · Adults older than 18 years with sepsis admitted to an ICU and receiving enteral nutrition; men and women
3 g7 days30
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study
2017 · L-carnitine plus simvastatin · People with mixed hyperlipidemia and elevated Lp(a), with LDL-C >160 mg/dL, TAG >150 mg/dL and Lp(a) >20 mg/dL; age and sex not specified
2 g12 weeks29
The effects of l-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial
2022 · l-Carnitine group · Critically ill patients admitted to the intensive care unit; age and sex not specified
3 g7 days27
The effects of adjunctive treatment with L-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial
2023 · L-carnitine group · Critically ill adults older than 18 years admitted to general ICUs; mixed underlying diagnoses
3 g7 days27
Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus
2006 · Simvastatin plus L-carnitine · Patients with type 2 diabetes mellitus
2 g60 days26
l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: A randomized double-blind placebo-controlled study
2023 · l-carnitine group · Adults aged 30–65 with pemphigus under corticosteroid therapy
2 g8 weeks24
Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients
2015 · LC group · Patients with coronary artery disease, identified by cardiac catheterization as having <50% stenosis of one major coronary artery; age and sex not specified
1 g12 weeks23
Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial
2014 · LC group · Men, mean age about 72 years, with coronary artery disease (CAD)
1 g12 weeks20
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
2000 · L-carnitine group · People with Lp(a) levels of 40–80 mg/dL, most with concomitant elevated LDL cholesterol and triglycerides; age and sex not reported
2 g—18
L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial
2005 · L-carnitine · Patients with genetically confirmed Friedreich's ataxia
3 g120 days16
Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases
2000 · L-carnitine group · Well-nourished patients aged 20–75 with carcinoma of the stomach, colon, liver, pancreas, kidney, or lung
2 g5 days14
Effects of acute L-carnitine supplementation on nitric oxide production and oxidative stress after exhaustive exercise in young soccer players
2015 · 3 g L-carnitine group · Healthy male soccer players aged 17–19 years
3 g1 day13
Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians
2005 · Group A, weeks 1–4 · Apparently healthy vegans and lacto-ovo-vegetarians
990 mg4 weeks11
L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress
2002 · LCLT supplement · Resistance-trained men; age and health condition not specified
2 g3 weeks10
The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery
2003 · L-carnitine L-tartrate (LCLT) supplementation · Healthy, recreationally weight-trained men, mean age 23.7 years
2 g3 weeks10
Androgenic responses to resistance exercise: effects of feeding and L-carnitine
2006 · L-carnitine L-tartrate (LCLT) · Resistance-trained men; mean age 22 years
2 g3 weeks10
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study
2007 · PLC alone · Adults with type 2 diabetes and erectile dysfunction; sex and age range not reported
2 g12 weeks8
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study
2007 · PLC plus sildenafil · Adults with type 2 diabetes and erectile dysfunction; sex and age range not reported
2 g12 weeks8
Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism
2025 · Carnitine repeated · Healthy adult volunteers, men and women; no stated disease
2.42 g7 days6
Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial
2003 · L-carnitine therapy · Infertile men aged 20–40 years selected for abnormal baseline sperm parameters
2 g60 days—
Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus
2005 · L-carnitine group · Adults with type II diabetes; 22 men and 13 women across the study, mean age 51.3 years
3 g12 weeks—
L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin
2008 · Group B · Patients with chronic hepatitis C treated with interferon alpha and ribavirin
2 g1 year—
Carbohydrate, protein, and fat metabolism during exercise after oral carnitine supplementation in humans
2008 · L-carnitine L-tartrate (LC) group · Active nonvegetarian males; age and health condition not specified
2 g2 weeks—
Oxidative stress in response to aerobic and anaerobic power testing: influence of exercise training and carnitine supplementation
2009 · GPLC-1 · 32 subjects; age, sex, and health condition not specified
1 g8 weeks—
Oxidative stress in response to aerobic and anaerobic power testing: influence of exercise training and carnitine supplementation
2009 · GPLC-3 · 32 subjects; age, sex, and health condition not specified
3 g8 weeks—
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients
2011 · sibutramine plus L-carnitine · Patients with uncontrolled type 2 diabetes mellitus (HbA1c >8.0%) receiving oral hypoglycemic agents or insulin; age and sex not reported
2 g1 year—
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients
2010 · orlistat plus L-carnitine · Adults with uncontrolled type 2 diabetes mellitus (HbA1c > 8.0%) receiving oral hypoglycemic agents or insulin
2 g1 year—
Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients
2010 · carnitine group · Hemodialysis patients; age range and sex not reported
1 g12 weeks—
Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial
2011 · carnitine group · Adults with end-stage kidney disease receiving hemodialysis; ages not reported; 15 men and 21 women across the study
1 g12 weeks—
Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial
2012 · carnitine group · Adult Lebanese men with hypertriglyceridemia, approximately 50 years old
1 g12 weeks—
A pilot trial of l-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury
2018 · LCA+ group · Patients with severe traumatic brain injury
2 g7 days—
Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients
2019 · glimepiride plus l-carnitine (group 2) · Adults with type 2 diabetes who had not achieved glycemic goals on glimepiride monotherapy
2 g26 weeks—
L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: a randomised controlled trial
2023 · LC · Patients with coronary artery disease (CAD); age range and sex not reported
1 g90 days—
L-Carnitine Tartrate Supplementation for 5 Weeks Improves Exercise Recovery in Men and Women: A Randomized, Double-Blind, Placebo-Controlled Trial
2021 · L-carnitine supplementation group (CAR) · Healthy men and women aged 21–65 years who participated in moderate physical activity at least 3 days per week
3 g37 days—
The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial
2022 · L-carnitine group · Overweight or obese reproductive-age women with polycystic ovary syndrome (PCOS)
1 g12 weeks—
L-Carnitine and synbiotic co-supplementation: beneficial effects on metabolic-endotoxemia, meta-inflammation, and oxidative-stress biomarkers in obese patients: a double blind, randomized, controlled clinical trial
2023 · L-carnitine mono-therapy with maltodextrin placebo · Obese female patients; age range not reported
1 g8 weeks—
Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans
2013 · Carnitine · Healthy males; age not reported
2.72 g12 weeks6
Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L-carnitine
1994 · L-carnitine · men with advanced AIDS (CDC stage IVCI) and normal serum carnitine levels
6 g2 weeks—
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial
2012 · L-Carnitine · Adults with advanced, irresectable UICC Stage IV pancreatic adenocarcinoma; mean age 64.4 years, both sexes
4 g12 weeks38
Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study
2007 · group A (carni Q-gel) · Patients with class II–IV heart failure
2.25 g12 weeks31
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · B1 · Infertile men with bacterial PVE, mean age 35 years (range 28–38)
2 g90 days23
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · B2 · Infertile men with bacterial PVE, mean age 35 years (range 28–38)
2 g90 days16
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · A1 · Infertile men with abacterial prostato-vesiculo-epididymitis (PVE), mean age 34 years (range 27–40)
2 g90 days14
Effects of acute L-carnitine supplementation on nitric oxide production and oxidative stress after exhaustive exercise in young soccer players
2015 · 4 g L-carnitine group · Healthy male soccer players aged 17–19 years
4 g1 day13
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · B3 · Infertile men with bacterial PVE, mean age 35 years (range 28–38)
2 g90 days12
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · A2 · Infertile men with abacterial PVE, mean age 34 years (range 27–40)
2 g90 days8
[Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis]
2001 · A3 · Infertile men with abacterial PVE, mean age 34 years (range 27–40)
2 g90 days8
Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism
2010 · group LC · Adults with impaired fasting glucose or type 2 diabetes mellitus
4 g10 days8
Effects of L-carnitine in patients with hepatic encephalopathy
2005 · group A · Patients with hepatic encephalopathy and cirrhosis; ages and sex not reported
4 g90 days—
L-Carnitine and synbiotic co-supplementation: beneficial effects on metabolic-endotoxemia, meta-inflammation, and oxidative-stress biomarkers in obese patients: a double blind, randomized, controlled clinical trial
2023 · L-carnitine + synbiotic co-supplementation · Obese female patients; age range not reported
1 g8 weeks—
Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial
2025 · co-supplementation · Metabolically healthy women with obesity
1 g8 weeks—
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders
2011 · L-carnitine group · Children aged 3–10 years with autism spectrum disorder
50 mg/kg90 days20
Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans
2011 · Carnitine · Healthy men, mean age 25.9 years
4 g24 weeks—
Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial
2014 · L-carnitine therapy group · Adults aged 20–85 years receiving hemodialysis with plasma free carnitine concentration below 40 μmol/L
20 mg/kg1 year88
Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial
2016 · levocarnitine group · Adults with carnitine deficiency undergoing maintenance hemodialysis
20 mg/kg1 year75
Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial
2022 · study group · men with asthenozoospermia and teratozoospermia
30 g90 days73
Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
2018 · Experimental group · Children aged 1 month to 13 years with dilated cardiomyopathy and NYHA class III–IV cardiac function
50 mg/kg1 year19
Effect of L-Carnitine Supplementation on Inflammatory Markers and Serum Glucose in Hemodialysis Children: A Randomized, Placebo-Controlled Clinical Trial
2022 · L-carnitine · Children aged 6–18 years receiving hemodialysis
50 mg/kg10 weeks12
Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis
1990 · Group 2 · Pediatric patients receiving continuous ambulatory peritoneal dialysis (CAPD)
100 mg/kg60 days—
Effects of Low Doses of L-Carnitine Tartrate and Lipid Multi-Particulate Formulated Creatine Monohydrate on Muscle Protein Synthesis in Myoblasts and Bioavailability in Humans and Rodents
2021 · Dose A · Healthy adults aged 18–30 years, male and female, without chronic disease
500 mg1 day15
Effects of Low Doses of L-Carnitine Tartrate and Lipid Multi-Particulate Formulated Creatine Monohydrate on Muscle Protein Synthesis in Myoblasts and Bioavailability in Humans and Rodents
2021 · Dose B · Healthy adults aged 18–30 years, male and female, without chronic disease
500 mg1 day15
Effects of Low Doses of L-Carnitine Tartrate and Lipid Multi-Particulate Formulated Creatine Monohydrate on Muscle Protein Synthesis in Myoblasts and Bioavailability in Humans and Rodents
2021 · Dose C · Healthy adults aged 18–30 years, male and female, without chronic disease
500 mg1 day15
[L-carnitine: safe and effective for asthenozoospermia]
2010 · Group A · Men with asthenozoospermia
2 g90 days68
[Huanshao Capsules combined with levocarnitine for the treatment of asthenospermia, oligospermia and teratozoospermia]
2018 · HSC+LC group · Men with infertility and spleen and kidney asthenia; age not reported
30 mL12 weeks60
Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians
2005 · Group A, weeks 5–8 · Apparently healthy vegans and lacto-ovo-vegetarians
990 mg4 weeks11
Short-term carnitine supplementation does not augment LCPomega3 status of vegans and lacto-ovo-vegetarians
2005 · Group B, weeks 5–8 · Apparently healthy vegans and lacto-ovo-vegetarians
990 mg4 weeks9
An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention
2016 · LAB4 ANTI · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon
600 mg90 days—
[Huanshao Capsules combined with levocarnitine for the treatment of asthenospermia, oligospermia and teratozoospermia]
2018 · Levocarnitine group · Men with infertility and spleen and kidney asthenia; age not reported
30 mL12 weeks59
Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial
2025 · mono-therapy · Metabolically healthy women with obesity
1 g8 weeks—